These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37654999)

  • 21. Tolerability and efficacy of a novel formulation in the treatment of melasma.
    Guevara IL; Werlinger KD; Pandya AG
    J Drugs Dermatol; 2010 Mar; 9(3):215-8. PubMed ID: 20232581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women.
    Lima PB; Dias JAF; Cassiano D; Esposito ACC; Bagatin E; Miot LDB; Miot HA
    Int J Dermatol; 2020 Dec; 59(12):1531-1536. PubMed ID: 32864760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical tranexamic acid as a promising treatment for melasma.
    Ebrahimi B; Naeini FF
    J Res Med Sci; 2014 Aug; 19(8):753-7. PubMed ID: 25422661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical isoniazid as a novel treatment for melasma: A randomized, double-blind, vehicle-controlled clinical trial.
    Ahramiyanpour N; Mahmoudi Z; Nezhad NZ; Khazaeli P; Amiri R; Kasraee B
    J Cosmet Dermatol; 2024 Apr; ():. PubMed ID: 38581222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma.
    Atefi N; Dalvand B; Ghassemi M; Mehran G; Heydarian A
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):417-424. PubMed ID: 28748406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
    Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
    Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Trichloro-Acetic Acid Peel Alone Versus Combined Topical Magnesium Ascorbyl Phosphate for Epidermal Melasma.
    Murtaza F; Bangash AR; Khushdil A; Noor SM
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):557-61. PubMed ID: 27504543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is topical zinc effective in the treatment of melasma? A double-blind randomized comparative study.
    Yousefi A; Khani Khoozani Z; Zakerzadeh Forooshani S; Omrani N; Moini AM; Eskandari Y
    Dermatol Surg; 2014 Jan; 40(1):33-7. PubMed ID: 24237751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
    Dayal S; Sahu P; Dua R
    J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
    Farshi S
    J Cosmet Dermatol; 2011 Dec; 10(4):282-7. PubMed ID: 22151936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma.
    Janney MS; Subramaniyan R; Dabas R; Lal S; Das NM; Godara SK
    J Cutan Aesthet Surg; 2019; 12(1):63-67. PubMed ID: 31057273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
    Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study.
    Viyoch J; Tengamnuay I; Phetdee K; Tuntijarukorn P; Waranuch N
    Curr Ther Res Clin Exp; 2010 Dec; 71(6):345-59. PubMed ID: 24688154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of therapeutic effects of conventional and liposomal form of 4% topical hydroquinone in patients with melasma.
    Taghavi F; Banihashemi M; Zabolinejad N; Salehi M; Jaafari MR; Marhamati H; Golnouri F; Dorri M
    J Cosmet Dermatol; 2019 Jun; 18(3):870-873. PubMed ID: 30105847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
    Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
    Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.